Please join the UNC Cancer Network for an online telehealth lecture with Rebecca Campo, PhD. Participants will learn to describe mind-body therapies within the scope of Complementary and Alternative Medicine (CAM), examine cancer survivors' use of mind-body therapies, and discuss the use of evidence-based mind-body therapies for managing treatment effects.
Pablo Ariel, Ph.D., Microscopy Services Laboratory, Pathology and Laboratory Medicine, UNC-CH
The UNC Mammalian Genotyping Core and Illumina invite you to join them for a free lunchtime seminar discussing the latest in Genomic Methylation Analysis. We will be discussing the new Methylation Array technology with a short review of the latest WGA Genotyping Platforms from Illumina as well as Next-Generation Sequencing techniques for Methylation Analysis.
This presentation of Cancer Transitions will be conducted in Spanish, and will runs from April 14 until May 19. Each weekly session lasts for 2 - 2 1/2 hours and includes information on nutrition, exercise, coping with stress, and medical care, plus delicious healthy snacks. This program is open to cancer patients who have completed treatment and their loved ones.
The UNC Eshelman School of Pharmacy will host the Tenth Annual Chapel Hill Pharmaceutical Sciences Conference May 12-13 in Kerr Hall on the campus of the University of North Carolina at Chapel Hill. The theme of PharmSci 2016 is Addressing Methodological and Ethical Issues in Pediatric Medication Safety Research.
AUDIENCE CHOICE! “p21-activated kinases as therapeutic targets in cancer” OR “The Mst tumor suppressors: when 2 - 1 = 3”
Jonathan Chernoff, MD, PhD, Fox Chase Cancer Center, Temple University
Donald (Chip) Bailey Jr., Co-Director, ADAPT Center for Cognitive/Affective Symptom Science, Director, Scholarship and Mentoring Core, ADAPT Center
May's seminar will feature career talks by a new Assistant Professor at UNC as well as an ITCMS trainee who recently accepted a position at an academic institution.
Evolution of Malignant Plasmacytoma cell lines from oral cancer-prone K14E7Fancd2-/-mouse long term marrow cultures
Joel Greenberger, MD, Professor and Chair, Radiation Oncology, University of Pittsburgh School of Medicine